Published: 2022-09-27

Pulmonary artery mycotic aneurism owing to aspergillus in SARS-CoV-2 convalescent: a case report and literature review

Daniel Benito Castillo Martinez, Doris Michelle Palacios Rivera, Jose Luis Ruiz Pier, Alvaro Mendoza Carranza


Invasive aspergillosis is a severe illness described in immune-compromised and critically ill non-immuno-compromised patients. Aspergillosis and COVID-19 co-infection cases harbor multiple unfavorable prognostic factors, with a 44% mortality versus 19% without aspergillosis. We presented the case of a 61-year-old man known with hypertension, diabetes, and smoking that went through COVID-19 infection, during the convalescent period presented multiple hemoptoic events due to A. fumigatus mycotic pseudoaneurysm, successfully resolved by selective angioembolization. Selective angioembolization is an effective alternative for high surgical risk due to comorbidities in the treatment of pulmonary mycotic aneurism.


Mycotic aneurism, Pulmonary aspergillosis, SARS-CoV-2

Full Text:



Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.

Cooper V, Bera R, Sherman R, Beed M. Pulmonary Artery Aneurysm Caused by Aspergillus Pneumonia Presenting as an Endobronchial Mass Lesion. J Intens Care Soc. 2013;14(3):263-5.

Tudesq JJ, Peyrony O, Lemiale V, Azoulay E. Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts. Semin Respir Crit Care Med. 2019;40(4):540-7.

Piracha S, Mahmood A, Qayyum N, Ganaie MB. Massive haemoptysis secondary to mycotic pulmonary artery aneurysm in subacute invasive aspergillosis. BMJ Case Rep. 2018;2018:bcr2017223088.

Ledoux MP, Guffroy B, Nivoix Y, Simand C, Herbrecht R. Invasive Pulmonary Aspergillosis. Semin Respir Crit Care Med. 2020;41(1):80-98.

Koehler P, Cornely OA, Böttiger BW, Dusse F, Eichenauer DA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528-34.

Marr KA, Platt A, Tornheim JA, Zhang SX, Datta K, Cardozo C, et al. Aspergillosis Complicating Severe Coronavirus Disease. Emerg Infect Dis. 2021;27(1):18-25.

Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):149-62.

Asai M, Houtte O, Sullivan TR, Garrido M, Pineda DM. Endovascular Repair of Three Concurrent Mycotic Pseudoaneurysms. Vasc Endovascular Surg. 2018;52(6):473-7.

Raper KB, Fennell DI. The genus Aspergillus. Baltimore: Williams and Wilkins; 1965: 686.

Latgé JP, Beauvais A. Functional duality of the cell wall. Curr Opin Microbiol. 2014;20:111-7.

Aimanianda V, Latgé JP. Fungal hydrophobins form a sheath preventing immune recognition of airborne conidia. Virulence. 2010;1(3):185-7.

Pini G, Faggi E, Donato R, Sacco C, Fanci R. Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses. 2008;51(2):117-22.

Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12(2):310-50.

Loussert C, Schmitt C, Prevost MC, Balloy V, Fadel E, Philippe B, et al. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol. 2010;12(3):405-10.

Rhodes JC. Aspergillus fumigatus: growth and virulence. Med Mycol. 2006;44:S77-81.

Vries RP, Visser J. Aspergillus enzymes involved in degradation of plant cell wall polysaccharides. Microbiol Mol Biol Rev. 2001;65(4):497-522.

Ries LN, Beattie SR, Espeso EA, Cramer RA, Goldman GH. Diverse Regulation of the CreA Carbon Catabolite Repressor in Aspergillus nidulans. Genetics. 2016;203(1):335-52.

Schrettl M, Kim HS, Eisendle M, Kragl C, Nierman WC, Heinekamp T, et al. SreA-mediated iron regulation in Aspergillus fumigatus. Mol Microbiol. 2008;70(1):27-43.

Haas H. Iron - A Key Nexus in the Virulence of Aspergillus fumigatus. Front Microbiol. 2012;3:28.

Brown NA, Goldman GH. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance. J Microbiol. 2016;54(3):243-53.

Moreno MA, Ibrahim-Granet O, Vicentefranqueira R, Amich J, Ave P, Leal F, et al. The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence. Mol Microbiol. 2007;64(5):1182-97.

Ding WY, Chan T, Yadavilli RK, McWilliams R. Aspergilloma and massive haemoptysis. BMJ Case Rep. 2014;2014:bcr2013200019.

Chen Y, Gilman MD, Humphrey KL, Salazar GM, Sharma A, Muniappan A, et al. Pulmonary Artery Pseudoaneurysms: Clinical Features and CT Findings. AJR Am J Roentgenol. 2017;208(1):84-91.

Koneru H, Biswas Roy S, Islam M, Abdelrazek H, Bandyopadhyay D, Madan N, et al. Pulmonary Artery Pseudoaneurysm: A Rare Cause of Fatal Massive Hemoptysis. Case Rep Pulmonol. 2018;2018:8251967.

Patrón M, Russo A, Sosa F, González SG, Esperón A. Experiencia en el tratamiento endovascular de pseudoaneurismas arteriales infecciosos: presentación de tres casos. Angiología. 2021;73(2):95-9.

Herbst N, Truong AD. A case of pulmonary artery pseudoaneurysm caused by invasive pulmonary aspergillosis. Chest. 2020;158.

Didier M, Guedin P, Staub F, Catherinot E, Rivaud E, Scherrer A, et al. Pulmonary arterial mycotic pseudoaneurysms in a patient with invasive pulmonary aspergillosis. Successful occlusion by coils. Am J Respir Crit Care Med. 2014;190(1):112-3.

Khalil A, Fedida B, Parrot A, Haddad S, Fartoukh M, Carette MF. Severe hemoptysis: From diagnosis to embolization. Diagn Interv Imaging. 2015;96(7-8):775-88.

Garg A, Chandrasekaran K, Jadhav S, Chandok G, Ringe A, Sankhe A. Intra-aneurysmal glue embolisation of a giant pulmonary artery pseudoaneurysm after left upper lobe lobectomy: case report. Korean J Radiol. 2013;14(3):455-9.

Bhatty D, Srivali N. Pulmonary artery pseudoaneurysm: a rare cause of hemoptysis. QJM. 2020;113(5):351-2.